Document Detail


Treatment emergent mania responding to valproate in a Chinese female adolescent population with eating disorders: a case series.
MedLine Citation:
PMID:  18567063     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Eating disorders are commonly associated with depressive symptoms. In an adolescent and binge eating population fluoxetine is commonly used to treat co-morbid depression associated with eating disorders. In some patients this may precipitate treatment emergent mania (TEM). Risk factors in the adolescent population include being older, female, having a longer duration of illness, more previous mood episodes, a higher prevalence of subclinical hypothyroidism, early-onset anxiety and recent exposure to a mood-elevating agent. Diagnosis and management of these co-morbid conditions is challenging due to the overlapping symptomatology and the adverse effects of both conditions complicating pharmacological management. This is illustrated with three cases in a Chinese female adolescent population that experienced TEM while on fluoxetine and responded to valproate.
Authors:
Phern Chern Tor; Ee Lian Lee
Related Documents :
16614553 - Attributional style in the eating disorders.
3591493 - Behavioral and psychological traits of weight-conscious teenagers: a comparison of eati...
18164483 - Deep brain stimulation for psychiatric disorders.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  European eating disorders review : the journal of the Eating Disorders Association     Volume:  16     ISSN:  1099-0968     ISO Abbreviation:  Eur Eat Disord Rev     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-10-29     Completed Date:  2008-12-31     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9436977     Medline TA:  Eur Eat Disord Rev     Country:  England    
Other Details:
Languages:  eng     Pagination:  421-6     Citation Subset:  IM    
Affiliation:
Department of Psychiatry, Singapore General Hospital, Singapore. torphernchern@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Anorexia Nervosa / complications,  drug therapy*
Anticonvulsants / therapeutic use
Antimanic Agents / therapeutic use
Bipolar Disorder / etiology*,  therapy*
Bulimia Nervosa / complications,  drug therapy*
Eating Disorders / complications*,  psychology*
Female
Humans
Isoxazoles / therapeutic use
Male
Phenytoin / therapeutic use
Risk Factors
Sex Characteristics
Singapore
Valproic Acid / therapeutic use*
Young Adult
Chemical
Reg. No./Substance:
0/Anticonvulsants; 0/Antimanic Agents; 0/Isoxazoles; 57-41-0/Phenytoin; 68291-97-4/zonisamide; 99-66-1/Valproic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Expectation and knowledge of pregnant women undergoing first and second trimester ultrasound examina...
Next Document:  Cross-cultural differences in the macronutrient intakes of women with anorexia nervosa in Australia ...